Approval · Notice of Compliance 7694 · 2006
GABAPENTIN: Notice of Compliance 7694
Issued January 17, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7694
- Date
- January 17, 2006
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antiepileptic agent
- Canadian reference product
- NEURONTIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GABAPENTIN | 02273853 | Cancelled Post Market |
Medicinal ingredients
- GABAPENTIN 300 MG per CAP